The subject of abortion is a lightening rod topic which may be among the most divisive. It is a relatively simple matter in the sense that a middle ground on the subject barely exists. One either takes the side of innocent human life and insists that abortion is immoral; or defends the notion that the rights of the mother to terminate a pregnancy transcends the human rights of that unborn child. Apart from those who are vocal or mobilized advocates for one side or the other, I suppose that the subject remains largely a private, personal matter and one acts upon it, if at all, based on their own convictions.
Only occasionally does information become available that exposes people who you would generally assume to be well outside the debate, but who are in reality very much a part of the advocacy for one side or the other. Such is the case with billionaire Warren Buffet, the head of Berkshire Hathaway Inc.
In an article in the New York Times Magazine, (starting on page 4 of this online version) it was disclosed that Buffet, contributed $3,000,000,000 (that’s three BILLION dollars) to a foundation in the name of his late wife, whose mission is to finance the training of medical students and doctors in abortion. Furthermore, Buffet was credited by the Wall Street Journal as being the source of funding for the so-called abortion pill. And the foundation was apparently a source of funding for the effort to overturn a partial birth abortion ban in Nebraska, where Buffet lives.
So, the matter is apparently not a private, personal matter for Buffet, but should perhaps be better considered a “cause,” deserving not just his emotional support, but serious financial investment as well.
This revelation about Buffet is helpful to me. It enables me to consider the kinds of decisions I make about the products I purchase, or choose not to purchase in the future, from companies that are under the corporate umbrella of Berkshire Hathaway. If you are so motivated, here is a list of companies that are subsidiaries of Berkshire Hathaway. I do not see a single one of them for which there is not a perfectly viable competitive alternative that might be more deserving of my consumer support.